Advertisement
Advertisement
U.S. Markets open in 6 hrs 15 mins
Advertisement
Advertisement
Advertisement
Advertisement

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.9400+0.3200 (+12.21%)
At close: 04:00PM EDT
2.9200 -0.02 (-0.68%)
After hours: 07:58PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/5/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.46
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 35.4100
52 Week Low 31.6000
50-Day Moving Average 32.5384
200-Day Moving Average 32.8885

Share Statistics

Avg Vol (3 month) 3364.02k
Avg Vol (10 day) 3435.59k
Shares Outstanding 550.19M
Implied Shares Outstanding 6N/A
Float 842.83M
% Held by Insiders 116.58%
% Held by Institutions 156.47%
Shares Short (Jul 14, 2022) 43.56M
Short Ratio (Jul 14, 2022) 43.64
Short % of Float (Jul 14, 2022) 46.97%
Short % of Shares Outstanding (Jul 14, 2022) 46.54%
Shares Short (prior month Jun 14, 2022) 45.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 28, 2014
Ex-Dividend Date 4Oct 30, 2014
Last Split Factor 21:12
Last Split Date 3Oct 30, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -42.32%
Operating Margin (ttm)-29.31%

Management Effectiveness

Return on Assets (ttm)-15.41%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)138.6M
Revenue Per Share (ttm)2.78
Quarterly Revenue Growth (yoy)51.30%
Gross Profit (ttm)78.27M
EBITDA -40.2M
Net Income Avi to Common (ttm)-58.65M
Diluted EPS (ttm)-2.1850
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)79.05M
Total Cash Per Share (mrq)1.45
Total Debt (mrq)257.61M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.62
Book Value Per Share (mrq)-2.20

Cash Flow Statement

Operating Cash Flow (ttm)-45.87M
Levered Free Cash Flow (ttm)-30.76M
Advertisement
Advertisement